Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beers

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Anesthesia and Analgesia|November 30, 2000
A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgeryR A Beers, J R Calimlim, E Uddoh, et al.
Biochemistry|June 18, 2003
Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2Stephen A Beers, Andrew G Buckland, Niroshini Giles, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1987
Kinetics of interstitially administered monoclonal antibodies for purposes of lymphoscintigraphyR L Wahl, O Geatti, M Liebert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptorsTammy L Unruh, Jonathan Zuccolo, Stephen A Beers, et al.
Cancer Research|June 7, 2017
TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-LetterAnna H Turaj, Lekh N Dahal, Stephen A Beers, et al.
Frontiers in Neurology|November 25, 2024
Case report: Polymorphous low-grade neuroepithelial tumor of the young and supratentorial ependymoma diagnosed in an adult maleCynthia Y Xu, Craig A Beers, Jian-Qiang Lu, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Systemic perfusion: a method of enhancing relative tumor uptake of radiolabeled monoclonal antibodiesR L Wahl, C R Piko, B A Beers, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Phosphatase inhibitors--III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphataseS A Beers, C F Schwender, D A Loughney, et al.
Frontiers in Oncology|September 8, 2023
The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, CanadaCraig A Beers, Gregory R Pond, James R Wright, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Anesthesia and Analgesia|November 30, 2000
A comparison of the cost-effectiveness of remifentanil versus fentanyl as an adjuvant to general anesthesia for outpatient gynecologic surgeryR A Beers, J R Calimlim, E Uddoh, et al.
Biochemistry|June 18, 2003
Effect of tryptophan insertions on the properties of the human group IIA phospholipase A2: mutagenesis produces an enzyme with characteristics similar to those of the human group V phospholipase A2Stephen A Beers, Andrew G Buckland, Niroshini Giles, et al.
Cancers|May 13, 2023
Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic StrategiesConstantinos Savva, Ellen Copson, Peter W M Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1987
Kinetics of interstitially administered monoclonal antibodies for purposes of lymphoscintigraphyR L Wahl, O Geatti, M Liebert, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptorsTammy L Unruh, Jonathan Zuccolo, Stephen A Beers, et al.
Cancer Research|June 7, 2017
TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-LetterAnna H Turaj, Lekh N Dahal, Stephen A Beers, et al.
Frontiers in Neurology|November 25, 2024
Case report: Polymorphous low-grade neuroepithelial tumor of the young and supratentorial ependymoma diagnosed in an adult maleCynthia Y Xu, Craig A Beers, Jian-Qiang Lu, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Systemic perfusion: a method of enhancing relative tumor uptake of radiolabeled monoclonal antibodiesR L Wahl, C R Piko, B A Beers, et al.
Bioorganic & Medicinal Chemistry|October 1, 1996
Phosphatase inhibitors--III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphataseS A Beers, C F Schwender, D A Loughney, et al.
Frontiers in Oncology|September 8, 2023
The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, CanadaCraig A Beers, Gregory R Pond, James R Wright, et al.
Pageof 12